Lin B - Search Results

1

O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation.

Zhu Q, Wang H, Chai S, Xu L, Lin B, Yi W, Wu L. Zhu Q, et al. Among authors: lin b. Proc Natl Acad Sci U S A. 2023 Mar 28;120(13):e2216796120. doi: 10.1073/pnas.2216796120. Epub 2023 Mar 21. Proc Natl Acad Sci U S A. 2023. PMID: 36943877 Free PMC article.

2

Single nucleotide polymorphisms in the metastasis-associated in colon cancer-1 gene predict the recurrence of hepatocellular carcinoma after transplantation.

Zheng Z, Gao S, Yang Z, Xie H, Zhang C, Lin B, Wu L, Zheng S, Zhou L. Zheng Z, et al. Among authors: lin b. Int J Med Sci. 2014 Jan 5;11(2):142-50. doi: 10.7150/ijms.7142. eCollection 2014. Int J Med Sci. 2014. PMID: 24465159 Free PMC article.

3

Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation.

Gao S, Lin BY, Yang Z, Zheng ZY, Liu ZK, Wu LM, Xie HY, Zhou L, Zheng SS. Gao S, et al. Int J Med Sci. 2014 Jan 21;11(3):268-75. doi: 10.7150/ijms.7769. eCollection 2014. Int J Med Sci. 2014. PMID: 24516351 Free PMC article.

4

MicroRNA-424 expression predicts tumor recurrence in patients with hepatocellular carcinoma following liver transplantation.

Wu L, Yang F, Lin B, Chen X, Yin S, Zhang F, Xie H, Zhou L, Zheng S. Wu L, et al. Among authors: lin b. Oncol Lett. 2018 Jun;15(6):9126-9132. doi: 10.3892/ol.2018.8539. Epub 2018 Apr 19. Oncol Lett. 2018. PMID: 29805644 Free PMC article.

5

Enzyme-responsive multifunctional peptide coating of gold nanorods improves tumor targeting and photothermal therapy efficacy.

Wu L, Lin B, Yang H, Chen J, Mao Z, Wang W, Gao C. Wu L, et al. Among authors: lin b. Acta Biomater. 2019 Mar 1;86:363-372. doi: 10.1016/j.actbio.2019.01.026. Epub 2019 Jan 16. Acta Biomater. 2019. PMID: 30660006

6

Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese.

Wu LM, He H, Chen G, Kuang Y, Lin BY, Chen XH, Zheng SS. Wu LM, et al. Hepatobiliary Pancreat Dis Int. 2020 Jun;19(3):252-257. doi: 10.1016/j.hbpd.2020.02.010. Epub 2020 Mar 12. Hepatobiliary Pancreat Dis Int. 2020. PMID: 32205038

7

Long non-coding RNA00844 inhibits MAPK signaling to suppress the progression of hepatocellular carcinoma by targeting AZGP1.

Lin B, He H, Zhang Q, Zhang J, Xu L, Zhou L, Zheng S, Wu L. Lin B, et al. Ann Transl Med. 2020 Nov;8(21):1365. doi: 10.21037/atm-20-3848. Ann Transl Med. 2020. PMID: 33313110 Free PMC article.

8

One-Step Enzymatic Labeling Reveals a Critical Role of O-GlcNAcylation in Cell-Cycle Progression and DNA Damage Response.

Tian Y, Zhu Q, Sun Z, Geng D, Lin B, Su X, He J, Guo M, Xu H, Zhao Y, Qin W, Wang PG, Wen L, Yi W. Tian Y, et al. Among authors: lin b. Angew Chem Int Ed Engl. 2021 Dec 6;60(50):26128-26135. doi: 10.1002/anie.202110053. Epub 2021 Nov 3. Angew Chem Int Ed Engl. 2021. PMID: 34590401

9

O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling.

Wu L, Cheng Y, Geng D, Fan Z, Lin B, Zhu Q, Li J, Qin W, Yi W. Wu L, et al. Among authors: lin b. Proc Natl Acad Sci U S A. 2022 Mar 8;119(10):e2107453119. doi: 10.1073/pnas.2107453119. Epub 2022 Mar 3. Proc Natl Acad Sci U S A. 2022. PMID: 35239437 Free PMC article.

10

Sialic Acid-Modified O-GlcNAc Transferase Inhibitor Liposome Presents Antitumor Effect in Hepatocellular Carcinoma.

Lin B, Chai S, Zhang Q, Lu Y, Hu J, Zhang J, Du YZ, Wu L. Lin B, et al. Mol Pharm. 2024 Jan 1;21(1):102-112. doi: 10.1021/acs.molpharmaceut.3c00451. Epub 2023 Nov 23. Mol Pharm. 2024. PMID: 37994899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,922 results

Search Page

Filters